SLSN: Solesence Beauty Company Short-Term Debt

Symbol and logo of brand Solesence Inc (SLSN)

Solesence Inc (SLSN) develops advanced mineral formulations for epidermis protection, leveraging the expertise of a team of chemists working in optimal labor conditions. This daily price chart reflects the asset's dynamics, where the indicator stands at 0.02. The company's revenues are based on the sale of proprietary sunscreen components, while management maintains profitability within normal ranges by controlling logistics risks within the raw materials sector.

SLSN (solesence.com) Company Short-Term Debts history from 04/09/2025 to 10/30/2026

Metric breakdowns and analytics for Solesence Beauty (SLSN)

- current quotes and average value forecast:
Price Chart Solesence Inc.|SLSN - Fair Value Consensus
- market capitalization information:
Market Value Solesence|SLSN - Real Price to Acquire Entire Company
- shareholders' equity book value data:
Book Value per Share Solesence Inc|SLSN - Book Capitalization|Market Cap to Net Assets Ratio solesence.com|SLSN - Aggregate Asset Value
- debt and liquidity data:
Debt to Equity Solesence Inc|SLSN - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Solesence Inc.|SLSN - Company Aggregate Debts|Debts to Book Capitalization Solesence|SLSN - Long-Term Debt Volume|Company Short-Term Debt Solesence Inc|Quick Liquidity solesence.com
- net income and valuation multiples indicators:
SLSN - Net Financial Result
Analysis of all company metrics:solesence.com (SLSN)
Mass-produced product of Solesence Inc.

Rising demand for eco-friendly components from Solesence Inc. (SLSN) correlates directly with the company's short-term debt dynamics. This indicator aggregates all liabilities with a maturity of up to twelve months. The total is calculated by summing current loans and short-term bonds. A decrease in this metric confirms the issuer's high liquidity and financial autonomy. A stable balance sheet ensures sustainable business development within the premium cosmetics segment.

Competitors of Solesence Inc

KRYS - Company Short-Term Debt|Company Short-Term Loans and Borrowings APGE (Apogee Therapeutics Inc)|Arcutis Biotherapeutics Inc (ARQT) - Company Short-Term Debt|Company Current Liabilities Vericel Inc.|ORKA (Oruka Therapeutics Inc) - Company Short-Term Debts|Company Short-Term Debts Sanara|Company Current Liabilities DBVT (DBV Technologies S.A.)|DERM (journeymedicalcorp.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debt Forte Biosciences, Inc FBRX|Short-Term Debt Volume Empro Corporation (EMPG)|SLGL - Company Short-Term Debt|AXIL - Company Short-Term Debts|MDCX: Company Short-Term Debts|VRCA - Short-Term Debt Volume|Company Short-Term Debt Hoth Therapeutics Inc.|Company Short-Term Indebtedness BFRI (Biofrontera Inc)|Company Short-Term Debt VYNE Therapeutics (VYNE)|Short-Term Debt Volume sonomapharma.com|Company Short-Term Debt Quoin Pharmaceuticals Ltd. QNRX|Azitra Inc (AZTR) - Short-Term Debt|DRMA - Company Short-Term Debt|ELAB: Company Short-Term Debt|RVNC: Company Short-Term Debts